Biogen Pharmachem Industries Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 200854,
    "name": "Biogen Pharma",
    "stock_name": "Biogen Pharma",
    "full_name": "Biogen Pharmachem Industries Ltd",
    "name_url": "stocks-analysis/biogen-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "0.28",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "0.28",
    "mcapval": "29.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531752,
    "symbol": "",
    "ind_name": "Non Banking Financial Company (NBFC)",
    "ind_code": 49,
    "sector_id": 51,
    "indexname": "India SENSEX",
    "isin": "INE703D01023",
    "curr_date": "Sep 24, 03:30 PM",
    "curr_time": "09:03 AM",
    "last_traded_at": "Sep 24, 03:30 PM IST",
    "bse_nse_vol": "18.97 lacs",
    "exc_status": "Active",
    "traded_date": "Sep 24, 2026",
    "traded_date_str": "2026 09 24",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/biogen-pharma-200854-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Markets Rally, But Biogen Pharmachem Industries Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biogen-pharmachem-industries-ltd-falls-to-52-week-low-of-rs025-4190025",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BiogenPharmache_priceRelatedfactors_4190025.png",
        "date": "2026-09-11 09:36:18",
        "description": "Despite a broadly positive market environment, Biogen Pharmachem Industries Ltd has plunged to a fresh 52-week low of Rs 0.25 on 11 Sep 2026, marking a steep 64.94% decline over the past year and underperforming the Sensex by a wide margin."
      },
      {
        "title": "Markets Rally, But Biogen Pharmachem Industries Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biogen-pharmachem-industries-ltd-falls-to-52-week-low-of-rs026-4150221",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BiogenPharmache_priceRelatedfactors_4150221.png",
        "date": "2026-08-12 10:40:57",
        "description": ""
      },
      {
        "title": "Biogen Pharmachem Industries Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/biogen-pharmachem-industries-ltd-is-rated-strong-sell-4141538",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BiogenPharmache_mojoScore_4141538.png",
        "date": "2026-08-07 10:11:24",
        "description": "Biogen Pharmachem Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 08 September 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 07 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Are Biogen Pharmachem Industries Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-biogen-pharmachem-industries-ltd-latest-results-good-or-bad-4140367",
        "imagepath": "",
        "date": "2026-08-06 19:22:06",
        "description": "Biogen Pharmachem Industries Ltd's latest financial results for Q1 FY27 reveal a complex picture characterized by erratic profitability and a concerning lack of revenue generation. The company reported a net profit of ₹0.22 crores, a recovery from a loss in the previous quarter, but this profit is not supported by any sales, as net sales remained at zero across all reported quarters. This raises significant questions about the sustainability of its business model.\n\nThe operating profit before depreciation, interest, and tax (PBDIT) also stood at ₹0.22 crores, indicating a sequential improvement from a negative figure in the preceding quarter. However, this performance is starkly contrasted by the ₹1.34 crores profit recorded in June 2025, highlighting a failure to maintain operational momentum. The absence of revenue generation is a critical concern, as the company appears to rely on sporadic profits from o..."
      },
      {
        "title": "Biogen Pharmachem Industries Q1 FY27: Modest Profit Reversal Fails to Mask Structural Weaknesses",
        "link": "https://www.marketsmojo.com/news/result-analysis/biogen-pharmachem-industries-q1-fy27-modest-profit-reversal-fails-to-mask-structural-weaknesses-4138897",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BiogenPharmache_quaterlyResult_4138897.png",
        "date": "2026-08-05 21:30:56",
        "description": "Biogen Pharmachem Industries Ltd., a micro-cap non-banking financial company, reported a net profit of ₹0.22 crores in Q1 FY27 (Jun'26), marking a reversal from the previous quarter's loss of ₹0.36 crores. However, this modest turnaround does little to address the company's fundamental challenges, as the stock continues its brutal descent, plummeting 63.75% over the past year and trading 64.20% below its 52-week high of ₹0.81. With a market capitalisation of just ₹32.00 crores and zero institutional backing, the company remains trapped in a bearish technical trend whilst grappling with negligible revenue generation and anaemic return ratios."
      },
      {
        "title": "Biogen Pharmachem Industries Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/biogen-pharmachem-industries-ltd-is-rated-strong-sell-4119140",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BiogenPharmache_mojoScore_4119140.png",
        "date": "2026-07-24 10:10:19",
        "description": "Biogen Pharmachem Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 08 Sep 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below represent the company’s current position as of 24 July 2026, providing investors with the latest insights into its performance and prospects."
      },
      {
        "title": "When is the next results date for Biogen Pharmachem Industries Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-biogen-pharmachem-industries-ltd-4116717",
        "imagepath": "",
        "date": "2026-07-22 23:17:15",
        "description": "The next results date for Biogen Pharmachem Industries Ltd is scheduled for August 5, 2026...."
      },
      {
        "title": "Five Consecutive Losses Push Biogen Pharmachem Industries Ltd to a New 52-Week Low",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biogen-pharmachem-industries-ltd-falls-to-52-week-low-of-rs027-4093855",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BiogenPharmache_priceRelatedfactors_4093855.png",
        "date": "2026-07-08 15:05:09",
        "description": ""
      },
      {
        "title": "Markets Rally, But Biogen Pharmachem Industries Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biogen-pharmachem-industries-ltd-falls-to-52-week-low-of-rs029-4087989",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BiogenPharmache_priceRelatedfactors_4087989.png",
        "date": "2026-07-03 15:35:30",
        "description": ""
      }
    ],
    "total": 114,
    "sid": "200854",
    "stock_news_url": "https://www.marketsmojo.com/news/biogen-pharmachem-industries-200854"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "17-Sep-2026",
      "details": "PFA",
      "source": "BSE"
    },
    {
      "caption": "Intimation Of Book Closure Pursuant To Regulation 42 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015.",
      "datetime": "04-Sep-2026",
      "details": "PFA",
      "source": "BSE"
    },
    {
      "caption": "Reg. 34 (1) Annual Report.",
      "datetime": "04-Sep-2026",
      "details": "Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are submitting herewith the Annual Report of the Company for the financial year 2025-26 along with the Notice of Annual General Meeting to be held on Tuesday 29th of September 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Biogen Pharmachem Industries Ltd has announced <strong>1:6</strong> bonus issue, ex-date: 15 May 26",
          "dt": "2026-05-15",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Markets Rally, But Biogen Pharmachem Industries Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-09-11 09:36:18

Despite a broadly positive market environment, Biogen Pharmachem Industries Ltd has plunged to a fresh 52-week low of Rs 0.25 on 11 Sep 2026, marking a steep 64.94% decline over the past year and underperforming the Sensex by a wide margin.

Read full news article

Markets Rally, But Biogen Pharmachem Industries Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-08-12 10:40:57

Read full news article

Biogen Pharmachem Industries Ltd is Rated Strong Sell

2026-08-07 10:11:24

Biogen Pharmachem Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 08 September 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 07 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Are Biogen Pharmachem Industries Ltd latest results good or bad?

2026-08-06 19:22:06

Biogen Pharmachem Industries Ltd's latest financial results for Q1 FY27 reveal a complex picture characterized by erratic profitability and a concerning lack of revenue generation. The company reported a net profit of ₹0.22 crores, a recovery from a loss in the previous quarter, but this profit is not supported by any sales, as net sales remained at zero across all reported quarters. This raises significant questions about the sustainability of its business model. The operating profit before depreciation, interest, and tax (PBDIT) also stood at ₹0.22 crores, indicating a sequential improvement from a negative figure in the preceding quarter. However, this performance is starkly contrasted by the ₹1.34 crores profit recorded in June 2025, highlighting a failure to maintain operational momentum. The absence of revenue generation is a critical concern, as the company appears to rely on sporadic profits from o...

Read full news article

Biogen Pharmachem Industries Q1 FY27: Modest Profit Reversal Fails to Mask Structural Weaknesses

2026-08-05 21:30:56

Biogen Pharmachem Industries Ltd., a micro-cap non-banking financial company, reported a net profit of ₹0.22 crores in Q1 FY27 (Jun'26), marking a reversal from the previous quarter's loss of ₹0.36 crores. However, this modest turnaround does little to address the company's fundamental challenges, as the stock continues its brutal descent, plummeting 63.75% over the past year and trading 64.20% below its 52-week high of ₹0.81. With a market capitalisation of just ₹32.00 crores and zero institutional backing, the company remains trapped in a bearish technical trend whilst grappling with negligible revenue generation and anaemic return ratios.

Read full news article

Biogen Pharmachem Industries Ltd is Rated Strong Sell

2026-07-24 10:10:19

Biogen Pharmachem Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 08 Sep 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below represent the company’s current position as of 24 July 2026, providing investors with the latest insights into its performance and prospects.